Cargando…

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease

Rifampicin is recommended for the treatment of Mycobacterium avium complex pulmonary disease alongside azithromycin and ethambutol. We evaluated the azithromycin-ethambutol backbone with and without rifampicin in an intracellular hollow fiber model and performed RNA sequencing to study the differenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schildkraut, Jodie A., Raaijmakers, Jelmer, Aarnoutse, Rob, Hoefsloot, Wouter, Wertheim, Heiman F. L., van Ingen, Jakko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649009/ https://www.ncbi.nlm.nih.gov/pubmed/37877693 http://dx.doi.org/10.1128/aac.00874-23

Ejemplares similares

Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease
por: Danho, Rabi, et al.
Publicado: (2022)

The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands
por: Schildkraut, Jodie Anne, et al.
Publicado: (2021)

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
por: Seijger, Charlotte, et al.
Publicado: (2019)

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases
por: Deshpande, Devyani, et al.
Publicado: (2016)

Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
por: Zweijpfenning, Sanne M.H., et al.
Publicado: (2021)

Subtle immunodeficiencies in nodular–bronchiectatic Mycobacterium avium complex lung disease
por: Bruno, Mariolina, et al.
Publicado: (2020)

MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus
por: Schildkraut, Jodie A., et al.
Publicado: (2022)

Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
por: Pearce, Camron, et al.
Publicado: (2020)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019)

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
por: van Ingen, Jakko, et al.
Publicado: (2020)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
por: Henriette Zweijpfenning, Sanne Maria, et al.
Publicado: (2022)

The tough process of unmasking the slow-growing mycobacterium: case report of Mycobacterium microti infection
por: van de Weg, Cornelia A. M., et al.
Publicado: (2019)

High mortality in patients with Mycobacterium avium complex lung disease: a systematic review
por: Diel, Roland, et al.
Publicado: (2018)

Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
por: Schuurbiers, Milou M.F., et al.
Publicado: (2020)

Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion
por: Mingora, Christina M., et al.
Publicado: (2022)

Mycobacterium xenopi Clinical Relevance and Determinants, the Netherlands
por: van Ingen, Jakko, et al.
Publicado: (2008)

A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

Epetraborole Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Rifabutin Is Active against Mycobacterium abscessus in Mice
por: Dick, Thomas, et al.
Publicado: (2020)

Characterization of Mycobacterium orygis
por: van Ingen, Jakko, et al.
Publicado: (2013)

Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2022)

Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2022)

Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
por: Madani, Abdeldjalil, et al.
Publicado: (2022)

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
por: Walter, Nicholas D., et al.
Publicado: (2023)

Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus
por: Van, Nhi, et al.
Publicado: (2023)

Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: te Brake, Lindsey H. M., et al.
Publicado: (2019)

Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus
por: Choules, Mary P., et al.
Publicado: (2019)

Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis
por: Berube, Bryan J., et al.
Publicado: (2017)

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies
por: Zhang, Nan, et al.
Publicado: (2020)

Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection
por: Negatu, Dereje A., et al.
Publicado: (2023)

TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus
por: Sarathy, Jickky Palmae, et al.
Publicado: (2020)

Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease
por: Negatu, Dereje A., et al.
Publicado: (2022)

Generalized Granuloma Annulare Treated with Monthly Rifampicin, Ofloxacin, and Minocycline Combination Therapy
por: Garg, Shilpa, et al.
Publicado: (2013)

Killing of Mycobacterium avium subspecies paratuberculosis within macrophages
por: Bannantine, John P, et al.
Publicado: (2002)

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
por: Palencia, Andrés, et al.
Publicado: (2016)

Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors
por: Berube, Bryan J., et al.
Publicado: (2019)

Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes
por: Shimomura, Hitoshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r1d0cu6o0pfbrnljr2bn9hvg2o